Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. CARMAT
  6. Summary
    ALCAR   FR0010907956

CARMAT

(ALCAR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
10/11/2021 10/12/2021 10/13/2021 10/14/2021 10/15/2021 Date
27.1(c) 27.25(c) 27.5(c) 27.5(c) 27.9(c) Last
19 523 14 802 13 911 6 617 9 445 Volume
-1.63% +0.55% +0.92% 0.00% +1.45% Change
More quotes
Estimated financial data (e)
Sales 2021 5,36 M 6,22 M 6,22 M
Net income 2021 -49,4 M -57,4 M -57,4 M
Net cash position 2021 6,10 M 7,08 M 7,08 M
P/E ratio 2021 -8,48x
Yield 2021 -
Sales 2022 17,8 M 20,6 M 20,6 M
Net income 2022 -48,3 M -56,1 M -56,1 M
Net Debt 2022 50,2 M 58,2 M 58,2 M
P/E ratio 2022 -9,04x
Yield 2022 -
Capitalization 428 M 497 M 497 M
EV / Sales 2021 78,7x
EV / Sales 2022 26,9x
Nbr of Employees 139
Free-Float 54,2%
More Financials
Company
Carmat SAS is a France-based Company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart and which is hydraulically activated. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical... 
More about the company
Ratings of CARMAT
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
-
More Ratings
All news about CARMAT
09/21CARMAT : Performs First Bioprosthetic Artificial Heart Implant in Female Patient
MT
09/21CARMAT : French company Carmat announces first implant of its artificial heart in a woman
RE
09/21CARMAT : announces first implant of its total artificial heart in a female recipient
PU
09/20CARMAT SA(ENXTPA : ALCAR) added to S&P Global BMI Index
CI
09/17GLOBAL MARKETS LIVE : Ryanair, Ford, Apple, Alphabet, Gap...
09/17CARMAT : Wins French Committee's Nod To Use Commercial Version Of Heart Device In Clinical..
MT
09/16CARMAT Receives Final Approval From the Patient Protection Committee for the Use of the..
CI
09/15CARMAT : 2021 interim financial report
PU
09/15GLOBAL MARKETS LIVE : Microsoft, Apple, The Boeing Company, AT&T, Activision Blizzard...
09/08CARMAT : French gender equality index
PU
09/06Certain Shares of Carmat SA are subject to a Lock-Up Agreement Ending on 6-SEP-2021.
CI
09/03GLOBAL MARKETS LIVE : Amazon, Delivery Hero, Walmart, Broadcom, JD.com, Didi Global...
09/03CARMAT Announces Appointment of Ivo Simundic as Sales Director for the DACH Region (Ger..
CI
09/03CARMAT : appoints Ivo Simundic as Sales director for the DACH region to support the deploy..
PU
08/27GLOBAL MARKETS LIVE : Nvidia, Microsoft, Dell, Apple, Uber...
More news
News in other languages on CARMAT
10/13EN DIRECT DES MARCHES : LVMH, Carrefour, Renault, Spie, Esker, Nvidia, Apple, SAP...
10/13STOCK MARKET PARIS : L'énergie flambe, les actions pas trop
09/21CAC40 : encore un scénario de reprise en 'V', avant FOMC FED
09/21Carmat réalise le premier implant de c?ur artificiel bioprothétique chez une patiente
09/21Les valeurs à suivre aujourd'hui à Paris - Mardi 21 septembre 2021
More news
Stock Trading Strategies
CARMAT - 2020
The calm spell can be taken advantage of to put on new positions
BUY
More Stock Trading Analysis
Chart CARMAT
Duration : Period :
CARMAT Technical Analysis Chart | ALCAR | FR0010907956 | MarketScreener
Technical analysis trends CARMAT
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 27,90 €
Average target price 41,50 €
Spread / Average Target 48,7%
EPS Revisions
Managers and Directors
StÚphane Piat Chief Executive Officer & Director
Alain Carpentier Honorary President
Pascale dĺArbonneau Chief Financial & Administrative Officer
Jean-Pierre Garnier Chairman
Marc GrimmÚ Director-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
CARMAT-1.41%497
STRYKER CORPORATION8.68%100 428
SMITH & NEPHEW PLC-15.43%15 431
INSPIRE MEDICAL SYSTEMS, INC.30.35%6 686
AXONICS, INC.26.52%2 911
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.-1.98%2 754